Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer
- PMID: 10565903
- PMCID: PMC85839
- DOI: 10.1128/JCM.37.12.3896-3900.1999
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer
Abstract
Oral mucosal colonization and infection with Candida are common in patients receiving radiation therapy for head and neck cancer. Infection is marked by oral pain and/or burning and can lead to significant patient morbidity. The purpose of this study was to identify Candida strain diversity in this population by using a chromogenic medium, subculturing, molecular typing, and antifungal susceptibility testing of clinical isolates. These results were then correlated with clinical outcome in patients treated with fluconazole for infection. Specimens from 30 patients receiving radiation therapy for head and neck cancer were cultured weekly for Candida. Patients exhibiting clinical infection were treated with oral fluconazole. All isolates were plated on CHROMagar Candida and RPMI medium, subcultured, and submitted for antifungal susceptibility testing and molecular typing. Infections occurred in 27% of the patients and were predominantly due to Candida albicans (78%). Candida carriage occurred in 73% of patients and at 51% of patient visits. Yeasts other than C. albicans predominated in carriage, as they were isolated from 59% of patients and at 52% of patient visits. All infections responded clinically, and all isolates were susceptible to fluconazole. Molecular typing showed that most patients had similar strains throughout their radiation treatment. One patient, however, did show the acquisition of a new strain. With this high rate of infection (27%), prophylaxis to prevent infection should be evaluated for these patients.
Figures
Similar articles
-
Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.Support Care Cancer. 2011 Jun;19(6):737-44. doi: 10.1007/s00520-011-1154-4. Epub 2011 Apr 10. Support Care Cancer. 2011. PMID: 21479787 Review.
-
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):79-83. doi: 10.1016/s0360-3016(03)00415-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909218 Clinical Trial.
-
Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China.Int J Oral Sci. 2009 Sep;1(3):156-62. doi: 10.4248/IJOS.09020. Int J Oral Sci. 2009. PMID: 20695081 Free PMC article.
-
The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.J Infect Dis. 2001 Jan 15;183(2):286-93. doi: 10.1086/317936. J Infect Dis. 2001. PMID: 11204125
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans.Antimicrob Agents Chemother. 2004 Jan;48(1):110-5. doi: 10.1128/AAC.48.1.110-115.2004. Antimicrob Agents Chemother. 2004. PMID: 14693527 Free PMC article.
-
Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.Support Care Cancer. 2011 Jun;19(6):737-44. doi: 10.1007/s00520-011-1154-4. Epub 2011 Apr 10. Support Care Cancer. 2011. PMID: 21479787 Review.
-
First isolation of Candida dubliniensis from oral cavities of dermatological patients in Nanjing, China.Mycopathologia. 2011 Dec;172(6):465-71. doi: 10.1007/s11046-011-9447-1. Epub 2011 Jul 17. Mycopathologia. 2011. PMID: 21769632
-
Pathogenesis of Candida albicans biofilm.Pathog Dis. 2016 Jun;74(4):ftw018. doi: 10.1093/femspd/ftw018. Pathog Dis. 2016. PMID: 26960943 Free PMC article. Review.
-
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.FEMS Microbiol Rev. 2021 May 5;45(3):fuaa060. doi: 10.1093/femsre/fuaa060. FEMS Microbiol Rev. 2021. PMID: 33232448 Free PMC article. Review.
References
-
- Boken D J, Swindels S, Rinaldi M G. Fluconazole-resistant Candida albicans. Clin Infect Dis. 1993;17:1018–1021. - PubMed
-
- Doebbling B N, Lehmenn R F, Hollis R J, Wu L C, Widmer A F, Voss A, Pfaller M A. Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis. 1993;16:377–383. - PubMed
-
- Fotos P G, Hellstein J W. Candida and candidosis. Dent Clin N Am. 1992;36:857–878. - PubMed
-
- Goodman J L, Winston D J, Greenfield R A, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;362:845–851. - PubMed
-
- Haveman C W, Redding S W. Dental management and treatment of xerostomic patients. Texas Dent J. 1998;115:43–56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical